Skip to main content
. 2021 May 20;8:668653. doi: 10.3389/fcvm.2021.668653

Table 6.

Analysis of laboratory tests and biomarkers results in AF and non-AF groups.

Sinus rhythm Atrial fibrillation p
NT-proBNP (pg/mL) 317.0 (190.5–649.5) 1,363.0 (483.0–2,360.0) <0.001
hs-cTnT (pg/mL) 9.6 (7.3–15.0) 22.3 (11.5–26.9) 0.015
Hemoglobin (g/dl) 13.40 (12.3–14.5) 13.80 (12.7–14.9) 0.608
Sodium (mmol/L) 141 (140.0–142.0) 142 (140.0–143.0) 0.020
Potassium (mmol/L) 4.4 (4.2–4.6) 4.5 (4.3–4.7) 0.506
Creatinine (μmol/L) 0.87 (0.71–1.02) 0.97 (0.78–1.21) 0.130
CRP (mg/L) 0.50 (0.5–0.77) 0.83 (0.5–1.62) 0.015
Uric acid (mg/dl) 6.05 (5.15–7.20) 7.10 (6.10–8.30) 0.001
Neprilysin (pg/mL) 458.628 (301.45–840.22) 437.927 (296.26–797.38) 0.88
Galectin-3 (ng/mL) 9.55 (7.54–13.02) 10.404 (7.58–13.72) 0.522
hs-CRP (μg/mL) 1.91 (0.90–3.82) 5.24 (2.71–10.86) 0.002
ST-2 (pg/mL) 32.40 (27.65–44.52) 66.37 (37.71–118.38) 0.207

Data are given as median (interquartile range) unless otherwise indicated. A p-value of <0.05 is considered statistically significant.

NA, perfect separation detected results not available.

NT-proBNP, N-terminal prohormone brain natriuretic peptide; hs-cTnT, high-sensitivity cardiac troponin T; CRP, C-reactive protein; hs-CRP, high-sensitivity C-reactive protein; ST-2, suppression of tumorigenicity 2. Bold values are statistically significant data.